340 related articles for article (PubMed ID: 30734055)
1. Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population-based matched cohort study.
Madsen LR; Baggesen LM; Richelsen B; Thomsen RW
Diabetologia; 2019 Apr; 62(4):611-620. PubMed ID: 30734055
[TBL] [Abstract][Full Text] [Related]
2. National Differences in Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery-Subgroup Analysis of 2-Year Results of the Diabetes Surgery Study Comparing Taiwanese with Americans with Mild Obesity (BMI 30-35 kg/m
Chong K; Ikramuddin S; Lee WJ; Billington CJ; Bantle JP; Wang Q; Thomas AJ; Connett JE; Leslie DB; Inabnet WB; Jeffery RW; Sarr MG; Jensen MD; Vella A; Ahmed L; Belani K; Schone JL; Olofson AE; Bainbridge HA; Laqua PS; Korner J; Chuang LM
Obes Surg; 2017 May; 27(5):1189-1195. PubMed ID: 27783367
[TBL] [Abstract][Full Text] [Related]
3. Diabetic retinopathy in people with Type 2 diabetes and obesity treated by Roux-en-Y gastric bypass compared with non-operated controls: with focus on the role of diabetes remission in a cross-sectional and a 6-year follow-up study.
Madsen LR; Bek T; Richelsen B
Diabet Med; 2019 Apr; 36(4):457-464. PubMed ID: 30537170
[TBL] [Abstract][Full Text] [Related]
4. Metabolic effects and safety of Roux-en-Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetes.
Feng W; Yin T; Chu X; Shan X; Jiang C; Wang Y; Qian Y; Zhu D; Sun X; Bi Y
Diabetes Metab Res Rev; 2019 Jul; 35(5):e3138. PubMed ID: 30740871
[TBL] [Abstract][Full Text] [Related]
5. "Dual-remission" after Roux-en-Y gastric bypass surgery: Glycemic variability cannot always be improved in Chinese obese patients with type 2 diabetes.
Yu H; Zhou J; Bao Y; Pin Zhang ; Lu W; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1312-1319. PubMed ID: 26823091
[TBL] [Abstract][Full Text] [Related]
6. Effect of Roux-en-Y Gastric Bypass on Remission of T2D: Medium-Term Follow-up in Chinese Patients with Different BMI Obesity Class.
Zhang H; Han X; Yu H; Di J; Zhang P; Jia W
Obes Surg; 2017 Jan; 27(1):134-142. PubMed ID: 27312346
[TBL] [Abstract][Full Text] [Related]
7. Effect of Roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m
Di J; Zhang H; Yu H; Zhang P; Wang Z; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1357-1363. PubMed ID: 27387699
[TBL] [Abstract][Full Text] [Related]
8. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial.
Cummings DE; Arterburn DE; Westbrook EO; Kuzma JN; Stewart SD; Chan CP; Bock SN; Landers JT; Kratz M; Foster-Schubert KE; Flum DR
Diabetologia; 2016 May; 59(5):945-53. PubMed ID: 26983924
[TBL] [Abstract][Full Text] [Related]
9. Cost-Utility of Laparoscopic Roux-en-Y Gastric Bypass in Chinese Patients with Type 2 Diabetes and Obesity with a BMI ≥ 27.5 kg/m2: a Multi-Center Study with a 4-Year Follow-Up of Surgical Cohort.
Tu Y; Wang L; Wei L; Xu Y; Han X; Han J; Yu H; Zheng C; Bao Y; Jia W
Obes Surg; 2019 Dec; 29(12):3978-3986. PubMed ID: 31338737
[TBL] [Abstract][Full Text] [Related]
10. Roux-en-Y gastric bypass versus best medical treatment for type 2 diabetes mellitus in adults with body mass index between 27 and 32 kg/m
Cheng A; Yeoh E; Moh A; Low S; Tan CH; Lam B; Sum CF; Subramaniam T; Lim SC
Diabetes Res Clin Pract; 2022 Jun; 188():109900. PubMed ID: 35513159
[TBL] [Abstract][Full Text] [Related]
11. Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study.
Moriconi D; Manca ML; Anselmino M; Rebelos E; Bellini R; Taddei S; Ferrannini E; Nannipieri M
Diabetes Metab; 2022 Jan; 48(1):101282. PubMed ID: 34547450
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Patient-Centered Outcomes in Obese Patients With Type 2 Diabetes 3 Years After Randomization to Roux-en-Y Gastric Bypass Surgery Versus Intensive Lifestyle Management: The SLIMM-T2D Study.
Simonson DC; Halperin F; Foster K; Vernon A; Goldfine AB
Diabetes Care; 2018 Apr; 41(4):670-679. PubMed ID: 29432125
[TBL] [Abstract][Full Text] [Related]
13. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial.
Mingrone G; Panunzi S; De Gaetano A; Guidone C; Iaconelli A; Capristo E; Chamseddine G; Bornstein SR; Rubino F
Lancet; 2021 Jan; 397(10271):293-304. PubMed ID: 33485454
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic gastric bypass for the treatment of type 2 diabetes: a comparison of Roux-en-Y versus single anastomosis gastric bypass.
Almalki OM; Lee WJ; Chong K; Ser KH; Lee YC; Chen SC
Surg Obes Relat Dis; 2018 Apr; 14(4):509-515. PubMed ID: 29555031
[TBL] [Abstract][Full Text] [Related]
15. Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Yan Y; Sha Y; Yao G; Wang S; Kong F; Liu H; Zhang G; Zhang H; Hu C; Zhang X
Medicine (Baltimore); 2016 Apr; 95(17):e3462. PubMed ID: 27124041
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric Bypass.
Park JY; Kim YJ
Obes Surg; 2016 Apr; 26(4):749-56. PubMed ID: 26205218
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Roux-en Y Gastric Bypass Versus Vertical Sleeve Gastrectomy for Sustained Remission of Type 2 Diabetes Mellitus.
Nudotor RD; Prokopowicz G; Abbey EJ; Gonzalez A; Canner JK; Steele KE
J Surg Res; 2021 May; 261():407-416. PubMed ID: 33515868
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for type 2 diabetes remission (ORDER): protocol of a multicentre, randomised controlled, open-label, superiority trial.
Li M; Liu Y; Lee WJ; Shikora SA; Robert M; Wang W; Wong SKH; Kong Y; Tong DKH; Tan CH; Zeng N; Zhu S; Wang C; Zhang P; Gu Y; Bai R; Meng F; Mao Z; Zhao X; Wu L; Liu Y; Zhang S; Zhang P; Zhang Z
BMJ Open; 2022 Sep; 12(9):e062206. PubMed ID: 36175102
[TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetes remission after Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and one anastomosis gastric bypass (OAGB): results of the longitudinal assessment of bariatric surgery study.
Moradi M; Kabir A; Khalili D; Lakeh MM; Dodaran MS; Pazouki A; Kermansaravi M; Alibeigi P; Moazenzadeh H; Abdolhosseini MR; Eghbali F; Baradaran HR
BMC Endocr Disord; 2022 Oct; 22(1):260. PubMed ID: 36289529
[TBL] [Abstract][Full Text] [Related]
20. Glycemic control and BMI changes after endoscopic implantation of a duodenojejunal bypass liner compared with laparoscopic Roux-en-Y gastric bypass surgery: a propensity score matching analysis.
Günthert SJ; Aksan A; Schröder O; Meyer G; Hausmann J; Stein J; Stier C
Surg Endosc; 2022 Aug; 36(8):5979-5985. PubMed ID: 35378626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
